Melanin-Concentrating Hormone (MCH): Role in REM Sleep and Depression

Pablo Torterolo1, Cecilia Scorza2, Patricia Lagos1

  • 1Department of Physiology, School of Medicine, Universidad de la República Montevideo, Uruguay.

Insights

Melanin-concentrating hormone (MCH) influences REM sleep and depressive behaviors. MCHergic system modulation offers potential therapeutic targets for sleep disorders and major depression.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Sleep Medicine

Background:

  • Melanin-concentrating hormone (MCH) is a neuromodulator produced in the hypothalamus and zona incerta.
  • MCH neurons project widely, influencing brain regions like the dorsal (DR) and median (MR) raphe nuclei, critical for sleep and mood regulation.
  • Major Depression (MD) is characterized by mood disturbances and altered sleep patterns, including shortened REM sleep latency.

Purpose of the Study:

  • To summarize and evaluate current data on the role of MCH in REM sleep regulation.
  • To explore the involvement of MCH in the pathophysiology of Major Depression (MD).

Main Methods:

  • Electrophysiological recordings and microdialysis techniques were employed.
  • Optogenetic stimulation and peptide microinjections into specific brain regions were utilized.
  • Pharmacological interventions, including antidepressant administration and MCH receptor antagonism, were investigated.

Main Results:

  • MCH neuron activity peaks during REM sleep, and MCH stimulation promotes sleep, particularly REM sleep.
  • MCH administration into the DR and MR induced depressive-like behaviors.
  • Antidepressants and MCH receptor antagonists counteracted MCH-induced depressive-like effects in the DR.
  • MCH was found to decrease the activity of serotonergic neurons in the DR.

Conclusions:

  • The MCHergic system plays a significant role in the control of REM sleep.
  • Experimental data strongly suggest MCH involvement in the pathophysiology of Major Depression.
  • Targeting the MCH system presents a potential therapeutic avenue for both sleep disturbances and depression.

Related Concept Videos

REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
2.4K
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
778
Understanding Sleep01:11

Understanding Sleep

Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
1.8K
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
831
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
3.2K
Stages of Sleep01:22

Stages of Sleep

Sleep progresses through distinct stages, each characterized by specific brain wave patterns and physiological responses ranging from wakefulness to stages of non-rapid eye movement, known as non-REM, to rapid eye movement, referred to as REM. Understanding these stages helps in recognizing how sleep supports various bodily and cognitive functions.
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
1.7K